RISK BASED INSPECTION [WHO TRS 986-POINT (12.6-12.10)]
![RISK BASED INSPECTION [WHO TRS 986-POINT (12.6-12.10)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-12.6-12.10-768x1086.jpg)
Risk-Based Inspection (RBI) is a methodology that rates manufacturing sites by the estimated risk they may pose to patients and product quality, and then plans the frequency, depth and breadth of inspection accordingly, using Quality Risk Management and site “signals”…





![RISK BASED INSPECTION [WHO TRS 986-POINT (12.4-12.5)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-12.4-12.5-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (12.1-12.3)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-12.1-12.3-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.16-11.20)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.16-11.20-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.14-11.15)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.14-11.15-768x1086.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.13)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.13-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (11.12)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.12-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.11)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.11-768x1086.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.9-11.10)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.9-11.10-768x1086.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.5-11.8)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.5-11.8-768x1086.jpg)